181 related articles for article (PubMed ID: 8549616)
1. Apomorphine produced more yawning in Sprague-Dawley rats than in F344 rats: a pharmacological study.
Tang AH; Himes CS
Eur J Pharmacol; 1995 Sep; 284(1-2):13-8. PubMed ID: 8549616
[TBL] [Abstract][Full Text] [Related]
2. Interactions of drugs acting on central dopamine receptors and cholinoceptors on yawning responses in the rat induced by apomorphine, bromocriptine or physostigmine.
Zarrindast MR; Poursoltan M
Br J Pharmacol; 1989 Apr; 96(4):843-8. PubMed ID: 2663110
[TBL] [Abstract][Full Text] [Related]
3. Dopamine agonist-induced yawning in rats: a dopamine D3 receptor-mediated behavior.
Collins GT; Witkin JM; Newman AH; Svensson KA; Grundt P; Cao J; Woods JH
J Pharmacol Exp Ther; 2005 Jul; 314(1):310-9. PubMed ID: 15833897
[TBL] [Abstract][Full Text] [Related]
4. [Effects of bifemelane on central dopaminergic and cholinergic systems in rats].
Ushijima I; Tsutsumi C; Hara T; Soeda K; Kishimoto O; Kaneyuki H; Mizuki Y; Yamada M
Yakubutsu Seishin Kodo; 1988 Dec; 8(4):463-70. PubMed ID: 2907957
[TBL] [Abstract][Full Text] [Related]
5. Yawning produced by dopamine agonists in rhesus monkeys.
Code RA; Tang AH
Eur J Pharmacol; 1991 Aug; 201(2-3):235-8. PubMed ID: 1686760
[TBL] [Abstract][Full Text] [Related]
6. Involvement of central beta-adrenoceptors in the regulation of yawning responses.
Yamada K; Matsumoto S; Nagashima M; Kumagai M; Kimura H; Furukawa T
Naunyn Schmiedebergs Arch Pharmacol; 1989 Jul; 340(1):26-30. PubMed ID: 2571945
[TBL] [Abstract][Full Text] [Related]
7. Locomotor inhibition, yawning and vacuous chewing induced by a novel dopamine D2 post-synaptic receptor agonist.
Smith HP; Nichols DE; Mailman RB; Lawler CP
Eur J Pharmacol; 1997 Mar; 323(1):27-36. PubMed ID: 9105873
[TBL] [Abstract][Full Text] [Related]
8. [Age-related modification of dopaminergic-cholinergic neuronal interaction in rats].
Kishimoto O
Yakubutsu Seishin Kodo; 1988 Dec; 8(4):443-51. PubMed ID: 3250156
[TBL] [Abstract][Full Text] [Related]
9. Multifocal sites of action involved in dopaminergic-cholinergic neuronal interactions in yawning.
Ushijima I; Mizuki Y; Yamada M
Psychopharmacology (Berl); 1988; 95(1):34-7. PubMed ID: 3133698
[TBL] [Abstract][Full Text] [Related]
10. Two inbred rat sublines that differ in spontaneous yawning behavior also differ in their responses to cholinergic and dopaminergic drugs.
Urbá-Holmgren R; Santos A; Holmgren B; Eguíbar JR
Behav Brain Res; 1993 Sep; 56(2):155-9. PubMed ID: 7902098
[TBL] [Abstract][Full Text] [Related]
11. Direct evidence for involvement of dopaminergic inhibition and cholinergic activation in yawning.
Yamada K; Furukawa T
Psychopharmacology (Berl); 1980 Jan; 67(1):39-43. PubMed ID: 6768077
[TBL] [Abstract][Full Text] [Related]
12. Yawning induced by apomorphine, physostigmine or pilocarpine is inhibited by electroconvulsive shock (ECS).
Wielosz M; Szymczyk H
Acta Physiol Hung; 1996; 84(4):473-5. PubMed ID: 9328636
[TBL] [Abstract][Full Text] [Related]
13. Modification of apomorphine-, physostigmine- and pilocarpine-induced yawning after long-term treatment with neuroleptic or cholinergic agents.
Ushijima I; Noda Y; Mizuki Y; Yamada M
Arch Int Pharmacodyn Ther; 1984 Oct; 271(2):180-8. PubMed ID: 6150689
[TBL] [Abstract][Full Text] [Related]
14. Muscarinic and nicotinic effects on yawning and tongue protruding in the rat.
Ushijima I; Yamada K; Inoue T; Tokunaga T; Furukawa T; Noda Y
Pharmacol Biochem Behav; 1984 Aug; 21(2):297-300. PubMed ID: 6541344
[TBL] [Abstract][Full Text] [Related]
15. Two distinctive apomorphine-induced phenotypes in the Roman high- and low-avoidance rats.
Giménez-Llort L; Cañete T; Guitart-Masip M; Fernández-Teruel A; Tobeña A
Physiol Behav; 2005 Nov; 86(4):458-66. PubMed ID: 16154604
[TBL] [Abstract][Full Text] [Related]
16. Apomorphine-induced penile erection and yawning: site of action in brain.
Melis MR; Argiolas A; Gessa GL
Brain Res; 1987 Jul; 415(1):98-104. PubMed ID: 3497688
[TBL] [Abstract][Full Text] [Related]
17. Penile erection and yawning induced by dopamine D2-like receptor agonists in rats: influence of strain and contribution of dopamine D2, but not D3 and D4 receptors.
Depoortère R; Bardin L; Rodrigues M; Abrial E; Aliaga M; Newman-Tancredi A
Behav Pharmacol; 2009 Jul; 20(4):303-11. PubMed ID: 19584712
[TBL] [Abstract][Full Text] [Related]
18. Proerectile effects of dopamine D2-like agonists are mediated by the D3 receptor in rats and mice.
Collins GT; Truccone A; Haji-Abdi F; Newman AH; Grundt P; Rice KC; Husbands SM; Greedy BM; Enguehard-Gueiffier C; Gueiffier A; Chen J; Wang S; Katz JL; Grandy DK; Sunahara RK; Woods JH
J Pharmacol Exp Ther; 2009 Apr; 329(1):210-7. PubMed ID: 19136638
[TBL] [Abstract][Full Text] [Related]
19. Post-synaptic 5-HT1A receptor involvement in yawning and penile erections induced by apomorphine, physostigmine and mCPP in rats.
Protais P; Windsor M; Mocaër E; Comoy E
Psychopharmacology (Berl); 1995 Aug; 120(4):376-83. PubMed ID: 8539317
[TBL] [Abstract][Full Text] [Related]
20. The mode of action of bromocriptine following pretreatment with reserpine and alpha-methyl-p-tyrosine in rats.
Ushijima I; Mizuki Y; Yamada M
Psychopharmacology (Berl); 1988; 95(1):29-33. PubMed ID: 2898789
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
